Gapping up
In reaction to earnings/guidance:
- X +6.4% (issues upside EPS guidance), CNC +2.3% (raises FY22 outlook ahead of Investor Day; authorizes $3.0 bln increase to existing stock repurchase program)
Other news:
- REV +81% (Reliance mulling buyout of REV according to Economic Times)
- EFC +5% (reports book value per share)
- JG +4.9% (receives RMB15 mln in special support funding from the Shenzhen Development and Reform Commission)
- CTRN +4.4% (names new CFO)
- ROKU +4.2% (ROKU and
- WMT announce partnership to bring comerce to TV ads)
- SRRA +3.8% (announces submission of new drug application for Momelotinib to FDA)
- BITF +3.8% (entered into an equipment financing agreement with initial funding of $37 million)
- BHC +3% (provides update on Solta Medical; IPO process suspended in light of market conditions)
- ZIP +2.9% (authorizes $150 mln increase to share repurchase program)
- REAX +2.5% (surpasses milestone of 5000 agents)
- BGS +2.4% (forms four business units)
- WPC +2.3% (increases dividend)
- UWMC +2.2% (CFO takes leave of absence for health reasons)
- ZI +1.8% (settles lawsuit with Bombora)
- TWI +1.6% (entered into a global long-term agreement with Deere (DE) on June 13 to supply wheels and tires)
- DAN +1.5% (awarded a $2.7 million (£2 million) grant to develop an e-Powertrain for OX Delivers)
- AJRD +1.4% (CEO Eileen Drake and Committee for Aerojet Rocketdyne Shareholders and Value Maximization Extremely Pleased with Delaware Court's Opinion)
- GVA +1.3% (awarded two contracts worth a combined $38 mln)
- OAS +1.2% (declares $15 special dividend in connection with closing of merger with WLL)
- OEC +1% (to raise prices for rubber carbon black products)
- JATT +1% (JATT Acquisition Corp and Zura Bio Limited announce definitive business combination agreement to create NYSE listed biotechnology company)
Analyst comments:
- AZEK +4.7% (upgraded to Buy from Neutral at BofA Securities)
- COF +2.1% (upgraded to Outperform from Neutral at Robert Baird)
- AXP +2% (upgraded to Outperform from Neutral at Robert Baird)